A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.
作者信息
Sampson Hugh A, Leung Donald Y M, Burks A Wesley, Lack Gideon, Bahna Sami L, Jones Stacie M, Wong Dennis A
出版信息
J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11.
PMID:21397314
Abstract
摘要
Zotero 插件